New Solution From Lumeta Assures Network Integrity During Completion of Mergers and Acquisitions
Posted on: Wednesday, 30 April 2008, 12:00 CDT
SOMERSET, N.J., April 30 /PRNewswire/ -- Lumeta, the leading provider of Network Assurance solutions for enterprises and government agencies, today announced the immediate availability of the company's M&A Solution, geared towards managing network change during mergers and acquisitions. Leveraging the latest version of its flagship network assurance solution, IPsonar(R) 4.0, the Lumeta M&A Solution empowers organizations to balance network change with risk management and compliance imperatives, enabling them to obtain complete visibility into network connectivity and behavior during the typically turbulent process of integrating separate networks and IT infrastructures.
Lumeta's IPsonar is a fully-automated, comprehensive solution which has been harnessed to intelligently streamline the M&A process and consolidate the networks of each organization involved. Only Lumeta's M&A Solution can give organizations global visibility into all the networks involved, giving a complete view of infrastructures, reducing the risk of security gaps, unaccounted infrastructure costs, or rogue network devices. Specifically, Lumeta's M&A Solution provides organizations with the intelligence to optimally drive consolidation efforts, empowering them to:
-- Plan and execute network consolidation using facts, not assumptions; -- Create an accurate baseline of the entire network before networks are merged and compare that to a subsequent scan after the merge; -- Identify unmanaged devices that may violate policy; -- Improve service availability during transitional periods; and -- Minimize security and compliance risks.
Clients such as Smiths Group successfully keep pace with the demands of business and IT challenges such as M&A and network consolidation using Lumeta's M&A Solution. Smiths Group used the solution to assist in consolidating three separate business divisions under the same managed service provider. Specifically, IPsonar was instrumental in determining the connections of every division, as well as the connections between divisions and partners. After the consolidation, Lumeta's solution enabled Smiths Group to monitor wireless connections and search for network leaks -- providing insight into updates to the network infrastructure and ensure compliance with security policies.
"To accurately know what's on our network, we needed an intelligent tool capable of mapping our entire network and quantifying risk, and found it with IPsonar. In fact, IPsonar is a key component of our M&A strategy because we're able to instantly assess the impact of network consolidation," said Raymond Ray, Group Infrastructure and Security Manager, Smiths Group. "Additionally, IPsonar gives us the ability to ensure that our ISPs are configuring the network properly because we have visibility into their activities -- we can better manage that relationship."
"The process of merging organizations' IT infrastructures, including their internal networks, can prove to be difficult, slow, and expensive. Network consolidation initiatives that are not planned or managed appropriately often result in service availability, security, or compliance problems," said Michael Markulec, chief operating officer, Lumeta. "Lumeta's M&A Solution enables organizations to understand all of their network connections, both old and new, and helps them manage those connections throughout the M&A process, streamlining and accelerating the daunting task of consolidating desperate networks."
For more information or to download a white paper on Lumeta's M&A Solution, please visit: http://www.lumeta.com/consolidation.
About Lumeta Corporation
Lumeta provides large enterprises and government agencies with the global visibility needed to quantify network risk and measure the impact of network change. Our network assurance solutions enable IT organizations to deploy new business services, maintain existing service levels and minimize network security risk to ensure compliant operations.
Lumeta's flagship product, IPsonar, is the industry's only solution that allows organizations to measure risk from a global network perspective. IPsonar maps every asset on a network-including assets not currently under management-visualizes the connectivity between assets and networks to uncover risk patterns and policy weaknesses, and enables network and security teams to bring unknown assets under management while deploying security technology more effectively to mitigate risk.
For more information, visit the Lumeta Web site at http://www.lumeta.com/.
Lumeta, the Lumeta logo, IPsonar and the IPsonar logo are trademarks and service marks of the Lumeta Corporation. Other product and company names appearing in this document may be trademarks of their respective owners.
Media Contact: Jim McManus Davies Murphy Group (781) 418-2402 lumeta@daviesmurphy.com
Lumeta Corporation
CONTACT: Jim McManus of Davies Murphy Group, +1-781-418-2402,lumeta@daviesmurphy.com, for Lumeta Corporation
Web site: http://www.lumeta.com/http://www.lumeta.com/consolidation
Source: PRNewswire
Related Articles
- Misys Credit Risk Vantage Unveiled as Latest Solution in Misys' Expanding Risk Management Portfolio
- Lumeta Network Baseline Solution Provides Complete Network Visibility
- Lumeta Introduces the Lumeta Network Index
- Phyhealth's Physhield Insurance Exchange Signs Management Agreement With USA Risk Group to Provide Captive Management Services
- Enterasys Networks Introduces Enterasys Sentinel, Industry's First Federated Solution for Secure Network Access Control
- Gather.Com Launches Free Social Networking Solution for Groups, Organizations and Clubs
- Factiva Deploys Tacit Networks'(R) Microsoft-Based WAN Optimization Solution to Securely Centralize Data and Speed Information to Field Offices
- Flu Vaccine Offered to High-Risk Groups
- Health Department Ready With Flu Shots: Vaccine to Be Available to High Risk Groups Until Oct. 24 When It Will Be Offered to General Public
- GeoPharma of Largo, Fla. Acquires Assets of Consolidated Pharmaceutical Group of Brooklyn
User Comments (0)

RSS Feeds